Hrt Financial LP Cure Vac N.V. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$6.69 - $12.25 $208,754 - $382,249	31,204 New	31,204 $325,000
Q2 2022 Aug 12, 2022	BUY	$13.18 - $19.41 $983,755 - $1.45 Million	74,640 Added 218.02%	108,876 $1.48 Million
Q1 2022 May 16, 2022	BUY	$14.73 - $35.25 $504,296 - $1.21 Million	34,236 New	34,236 $671,000
Q2 2021 Aug 16, 2021	SELL	$56.91 - $127.53 $2.5 Million - $5.61 Million	-44,007 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$79.79 - $126.29 $3.07 Million - $4.85 Million	38,434 Added 689.65%	44,007 $4.02 Million
Q4 2020 Feb 16, 2021	SELL	$46.76 - $136.27 $29,692 - $86,531	-635 Reduced 10.23%	5,573 $451,000
Q3 2020 Nov 13, 2020	BUY	$43.8 - $77.2 $271,910 - $479,257	6,208 New	6,208 $288,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.